Fingerprint
Dive into the research topics where Elimelech Okon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Can CD44 be a mediator of cell destruction? the challenge of type 1 diabetes
Assayag-Asherie, N., Sever, D., Bogdani, M., Johnson, P., Weiss, T., Ginzberg, A., Perles, S., Weiss, L., Sebban, L. E., Turley, E. A., Okon, E., Raz, I. & Naor, D., 1 Dec 2015, In: PLoS ONE. 10, 12, e0143589.Research output: Contribution to journal › Article › peer-review
Open Access19 Scopus citations -
Different patterns of expression of the erbB family of receptor tyrosine kinases in common nevi, dysplastic nevi, and primary malignant melanomas: An immunohistochemical study
Feinmesser, M., Veltman, V., Morgenstern, S., Tobar, A., Gutman, H., Kaganovsky, E., Tzabari, C., Sulkes, J. & Okon, E., Oct 2010, In: American Journal of Dermatopathology. 32, 7, p. 665-675 11 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
Novel histochemical stain for tinctorial detection of cancer and neoplastic cells
Idelevich, P., Kristt, D., Okon, E., Terkieltaub, D., Rivkin, I., Fishman, A., Lew, S., Schejter, E. & Elkeles, A., Sep 2009, In: Journal of Histotechnology. 32, 3, p. 97-105 9 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma
Broyde, A., Boycov, O., Strenov, Y., Okon, E., Shpilberg, O. & Bairey, O., Jun 2009, In: American Journal of Hematology. 84, 6, p. 338-343 6 p.Research output: Contribution to journal › Article › peer-review
132 Scopus citations -
Gelatinous transformation of bone marrow in chronic myeloid leukemia during treatment with imatinib mesylate: A disease or a drug effect?
Ram, R., Gafter-Gvili, A., Okon, E., Pazgal, I., Shpilberg, O. & Raanani, P., Apr 2008, In: Acta Haematologica. 119, 2, p. 104-107 4 p.Research output: Contribution to journal › Article › peer-review
20 Scopus citations